Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction in Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)

NCT03072979 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT03072979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03072979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction in Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Unknown status
Start date
January 21, 2017
Completion date
December 31, 2018
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spine metastasis